InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.78
(
-0.16%
)
Bitcoin
57,654.36
(
-4.17%
)
Post# of 24568
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

colorofmoney

Send PM Follow Ignore
Followers 88
Posts 12370
Boards Moderated 1
Alias Born 07/24/2009

colorofmoney

Re: None

Thursday, 10/08/2009 3:23:43 PM

Thursday, October 08, 2009 3:23:43 PM

Post# of 24568
Subscriber Alert From BioMedReports.Com

On Friday at BioMedReports, Dr. William A. Carter, CEO of Hemispherx BioPharma, Inc. (AMEX:HEB) is expected to share some important news about the company's pending FDA decision and some new information about the company's Alferon LDO (Low Dose Oral) application
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up